Monday, October 20, 2014
Wednesday, September 24, 2014
Medical oncologist Paul Sabbatini sheds light on how phase I clinical trials are conducted at Memorial Sloan Kettering and how to determine whether patients may be eligible for one.
Monday, August 4, 2014
Wednesday, July 9, 2014
Monday, June 30, 2014
Psychiatrist William Breitbart answers questions about coping with the debilitating exhaustion that can result from cancer treatment.
Monday, June 16, 2014
Memorial Sloan Kettering social workers offer advice on managing some of the challenges of living with advanced cancer.
In the Community
Friday, April 18, 2014
Memorial Sloan Kettering is tackling health disparities that persist in medically underserved communities.
Thursday, April 17, 2014
Molecular analysis of lung tumors can help guide treatment decisions. Memorial Sloan Kettering is one of only a handful of centers nationwide to offer this personalized approach to care.
Ask the Expert
Friday, April 4, 2014
Memorial Sloan Kettering social worker Carrie Panzer offers tips for coping with hair loss.
Monday, March 24, 2014
Social worker Karen Hartman shares coping strategies that cancer survivors can use to lessen fear of recurrence as they adjust to life after treatment.
In the Clinic
Monday, March 17, 2014
A high-dose radiation treatment that can be given in one day has become an effective and increasingly common approach for patients with metastatic brain tumors.
Friday, January 31, 2014
A recent web chat features medical oncologist Steven M. Horwitz discussing advances in the diagnosis and treatment of lymphoma.
Wednesday, January 15, 2014
Connections gives patients and caregivers an online meeting place where they can exchange advice, get support, and connect with the Memorial Sloan Kettering community.
Monday, January 6, 2014
Immunologist Alexander Rudensky and medical oncologist and immunologist Jedd Wolchok are investigating innovative ways to use the immune system to fight cancer.
In the Clinic
Friday, November 15, 2013
Memorial Sloan Kettering experts are leading investigations of a procedure called hyperthermic intraperitoneal chemotherapy, also known as HIPEC.